FDA product code OPP: Pump, Infusion, Insulin Bolus
OPP is the FDA product code for pump, infusion, insulin bolus. It is a Class II device, regulated under 21 CFR 880.5725 and reviewed by the Clinical Chemistry panel. FDA has cleared 7 510(k) submissions under OPP, 3 in the last five years, from 3 different applicants. The average 510(k) review took 144 days (median 112); 142 days on average over the last three years. FDA has posted 1 recall for OPP devices.
Definition
The device is adhered to the body for several days for the purpose of periodically infusing an insulin bolus.
Classification
| Field | Value |
|---|---|
| Device name | Pump, Infusion, Insulin Bolus |
| Device class | Class II |
| Regulation | 21 CFR 880.5725 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | General Hospital |
| Premarket route | 510(k) |
510(k) clearances per year for OPP
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 1 | 189 |
| 2024 | 2 | 60 |
| 2026 | 1 | 224 |
Compare with all 510(k) review times · Search every OPP clearance
Top OPP applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Cequr SA | 3 | 2026-04-10 |
| Calibra Medical, Inc. | 3 | 2012-04-10 |
| Lifescan Europe, A Division of Cilag GmbH | 1 | 2017-06-07 |
Most recent OPP clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K252757 | Cequr SA | CeQur Simplicity On-Demand Insulin Delivery System | 2026-04-10 | 224 |
| K243273 | Cequr SA | CeQur Simplicity On-Demand Insulin Delivery System | 2024-11-13 | 28 |
| K233447 | Cequr SA | CeQur Simplicity On-Demand Insulin Delivery System | 2024-01-18 | 91 |
| K163357 | Lifescan Europe, A Division of Cilag GmbH | OneTouch Via On-Demand Insulin Delivery System | 2017-06-07 | 189 |
| K111924 | Calibra Medical, Inc. | FINESSE PERSONAL INSULIN DELIVERY PATCH | 2012-04-10 | 279 |
Recalls for OPP devices
1 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2011-06-13.
HCPCS codes with matching descriptors
Text match between the FDA device name and CMS descriptors, not an official crosswalk:
- A4220 — Refill kit for implantable infusion pump
- E0786 — Implantable programmable infusion pump, replacement (excludes implantable intraspinal catheter)
- E0785 — Implantable intraspinal (epidural/intrathecal) catheter used with implantable infusion pump, replacement
Frequently asked questions
What is FDA product code OPP?
OPP is the FDA product code for pump, infusion, insulin bolus. It is a Class II device, regulated under 21 CFR 880.5725 and reviewed by the Clinical Chemistry panel.
What device class is OPP?
Class II, regulation 21 CFR 880.5725. Typical premarket route: 510(k).
How long does a 510(k) take for product code OPP?
Across 7 cleared submissions the average was 144 days from receipt to decision (median 112).
Which companies have the most OPP clearances?
Cequr SA (3); Calibra Medical, Inc. (3); Lifescan Europe, A Division of Cilag GmbH (1).
Have OPP devices been recalled?
Yes: 1 product recalls across 1 recall events; the most recent began 2011-06-13.
Next steps
- Run an FDA pathway report with predicate devices for product code OPP
- Run a recall and safety report across every OPP manufacturer
- Watch product code OPP for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times